GlassScriptPhysician profile
Neema Bayran
NPI 1780611756
$2,353.59
in general payments reported to CMS, 2019-2025
12 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $318 · 2021: $181 · 2022: $450 · 2023: $578 · 2024: $401 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $466.59 | 2021-2023 | Intellis Adaptivestim |
| Abbott Laboratories | $376.08 | 2019-2024 | Eterna |
| Saluda Medical Americas, INC. | $333.26 | 2024-2025 | Evoke |
| Medtronic USA, INC. | $242.48 | 2019-2020 | |
| Boston Scientific Corporation | $233.34 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Electronic Waveform Lab, INC. | $219.70 | 2023 | |
| Siemens Medical Solutions USA, INC. | $206.35 | 2022-2023 | Cios Flow |
| Curonix LLC | $105.52 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $65.00 | 2023 | Sprint Pns System |
| Si-Bone, INC. | $46.77 | 2020 | |
| Nevro Corp. | $40.81 | 2021-2023 | Senza |
| Spinal Simplicity, LLC | $17.69 | 2023 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neema Bayran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.